Is incremental hemodialysis ready to return on the scene? From empiricism to kinetic modelling

Journal of Nephrology

Volumn 30, Issue 4, 2017, Pages 521-529

  Basile, Carlo ^a   Casino, Francesco Gaetano ^a,b   Kalantar Zadeh, Kamyar ^c,d,e  

^a MIULLI GENERAL HOSPITAL   (Italy)

^b SM2 Dialysis Center   (Italy)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

End stage renal disease; Incremental hemodialysis; Initiation of dialysis; Residual renal function; Twice weekly hemodialysis; Urea kinetic modelling

Indexed keywords

CARDIOVASCULAR DISEASE ASSESSMENT; DECISION MAKING; DIALYSER UREA CLEARANCE; EMPIRICISM; FLUID THERAPY; GLOMERULUS FILTRATION RATE; HEMODIALYSIS; HOMEOSTASIS; INTERDIALYTIC WEIGHT GAIN; KIDNEY FUNCTION; KINETICS; NUTRITIONAL STATUS; PERITONEAL DIALYSIS; QUALITY OF LIFE; RENAL CLEARANCE; RENAL UREA CLEARANCE; REVIEW; SURVIVAL; ULTRAFILTRATION; UREMIA; WEIGHT GAIN; BIOLOGICAL MODEL; HUMAN; KIDNEY; KIDNEY DISEASE; KIDNEY FUNCTION TEST; MORTALITY; PATHOPHYSIOLOGY; PROCEDURES; RISK FACTOR; TREATMENT OUTCOME;

HUMANS; KIDNEY; KIDNEY DISEASES; KIDNEY FUNCTION TESTS; KINETICS; MODELS, BIOLOGICAL; RENAL DIALYSIS; RISK FACTORS; TREATMENT OUTCOME;

EID: 85021702815     PISSN: 11218428     EISSN: 17246059     Source Type: Journal    
DOI: 10.1007/s40620-017-0391-0     Document Type: Review

References (72)

1. Saran R, Li Y, Robinson B et al (2016) US renal data system 2015 annual data report: epidemiology of kidney disease in he US. Am J Kidney Dis 67(Suppl 1):S1–S305
2. Toth-Manikowski SM, Shafi T (2016) Hemodialysis prescription for incident patients: twice seems nice, bt is it incremental? Am J Kidney Dis 68:180–183
3. Lowrie EG, Laird NM, Parker TF et al (1981) Effect of the hemodialysis prescription of patient morbidity: report from the National Cooperative Dialysis Study. N Engl J Med 305:1176–1181
4. Eknoyan G, Beck GJ, Cheung AK et al (2002) Effect of dialysis dose and membrane flux in maintenance hemodialysis. N Engl J Med 347:2010–2019
5. Blagg CR (2011) The 50th anniversary of long-term hemodialysis: University of Washington Hospital, March 9th, 1960. J Nephrol 24(Suppl 17):S84–S88
6. (2001)NKF-K/DOQI clinical practice guidelines for hemodialysis adequacy:update 2000. Am J Kidney Dis 37(Suppl 1):S7–S64
7. Chertow GM, Levin NW, Beck GJ et al (2010) In-center hemodialysis six times per week versus three times per week. N Engl J Med 363:2287–2300
8. Couchoud C, Kooman J, Finne P et al (2009) From registry data collection to international comparisons: examples of haemodialysis duration and frequency. Nephrol Dial Transplant 24:217–224
9. Rhee CM, Unruh M, Chen J et al (2013) Infrequent dialysis: a new paradigm for hemodialysis initiation. Semin Dial 26:720–727
10. Zhang M, Wang M, Li H et al (2014) Association of initial twice-weekly hemodialysis treatment with preservation of residual kidney function in ESRD patients. Am J Nephrol 40:140–150
11. Daugirdas JT, Green T, Rocco MV et al (2013) Effect of frequent hemodialysis on residual kidney function. Kidney Int 83:949–958
12. Golper TA, Mehrotra R (2015) The intact nephron hypothesis in reverse: an argument to support incremental dialysis. Nephrol Dial Transplant 30:1602–1604
13. Sandrini M, Vizzardi V, Valerio F et al (2016) Incremental peritoneal dialysis: a 10 year single-centre experience. J Nephrol 29:871–879
14. Hanson JA, Hulbert-Shearon TE, Ojo AO et al (1999) Prescription of twice-weekly hemodialysis in the USA. Am J Nephrol 19:625–633
15. Lin YF, Huang JW, Wu MS et al (2009) Comparison of residual renal function in patients undergoing twice-weekly versus three-times-weekly haemodialysis. Nephrology (Carlton) 14:59–64
16. Supasyndh O, Satirapoj B, Seenamngoen S et al (2009) Nutritional status of twice and thrice-weekly hemodialysis patients with weekly Kt/V > 3.6. J Med Assoc Thai 92:624–631
17. Vilar E, Wellsted D, Chandna SM et al (2009) Residual renal function improves outcome in incremental hemodialysis despite reduced dialysis dose. Nephrol Dial Transplant 24:2502–2510
18. Stankuviene A, Ziginskiené E, Kuzminskis V et al (2010) Impact of hemodialysis dose and frequency on survival of patients on chronic hemodialysis in Lithuania during 1998–2005. Medicina (Kaunas) 46: 516–521
19. Lin X, Yan Y, Ni Z et al (2012) Clinical outcome of twice-weekly hemodialysis in Shangai. Blood Purif 33:66–72
20. Elamin S, Abu-Aisha H (2012) Reaching target hemoglobin level and having a functioning arteriovenous fistula significantly improve one year survival in twice weekly hemodialysis. Arab J Nephrol Transplant 5:81–86
21. Fernandez-Lucas M, Teruel-Briones JL, Gomis-Couto A et al (2012) Maintaining residual renal function in patients on haemodialysis: 5-year experience uing a progressively increasing dialysis regimen. Nefrologia 32:767–776
22. Caria S, Cupisti A, Sau G et al (2014) The incremental treatment of ESRD: a low-protein diet combined with weekly hemodialysis may be beneficial for selected patients. BMC Nephrol 15:172
23. Park JI, Park JT, Kim JL et al (2017) Comparison of outcoms between the incremental and thrice-weekly initiation of hemodialysis: a propensity-matched study of a prospective cohort in Korea. Nephrol Dial Transplant 32:355–362
24. Obi Y, Streja E, Rhee CM et al (2016) Incremental hemodialysis, residual kidney function, and mortality risk in incident dialysis patients: a cohort study. Am J Kidney Dis 68:256–265
25. Obi Y, Rhee CM, Mathew AT et al (2016) Residual kidney function decline and mortality in incident hemodialysis patients. J Am Soc Nephrol 27:3758–3768
26. Mathew AT, Obi Y, Rhee CM et al (2016) Treatment frequency and mortality among incident hemodialysis patients in the US comparing incremental standard and more frequent dialysis. Kidney Int 90:1071–1079
27. Smith HW, Goldring W, Chasis H (1938) The measurement of the tubular excretory mass, effective blood flow and filtration rate in the normal human kidney. J Clin Invest 17:263–278
28. Davenport A (2016) Measuring residual renal function in dialysis patients: can we dispense with 24-hour urine collections? Kidney int 89:978–980
29. van Olden RW, van Acker BA, Koomen GC et al (1995) Time course of inulin and creatinine clearance in the interval between two haemodialysis treatments. Nephrol Dial Transplant 10:2274–2280
30. Wong J, Vilar E, Davenport A et al (2015) Incremental haemodialysis. Nephrol Dial Transplant 30:1639–1648
31. Bhavsar N, Appel L, Kusek J et al (2011) Comparison of measured GFR, serum creatinine, cystatin C, and beta-trace protein to predict ESRD in African Americans with hypertensive CKD. Am J Kidney Dis 58:886–893
32. Shafi T, Michels WM, Levey AS et al (2016) Estimating residual kidney function in dialysis patients without urine collection. Kidney Int 89:1099–1110
33. 2-microglobulin. Kidney Int 89:1090–1098
34. Kalantar-Zadeh K, Unruh M, Zager PG et al (2014) Twice-weekly and incremental hemodialysis treatment for initiation of kidney replacement therapy. Am J Kidney Dis 64:181–186
35. Kalantar-Zadeh K, Casino FG (2014) Let us give twice-weekly hemodialysis a chance: revisiting the taboo. Nephrol Dial Transplant 29:1618–1620
36. Shafi T, Jaar BG, Plantinga LC et al (2010) Association of residual urine output with mortality, quality of life, and inflammation in incident hemodialysis patients: the Choices for Healthy Outcomes in Caring for End-Stage Renal Disease (CHOICE) study. Am J Kidney Dis 56:348–358
37. van der Wal WM, Noordzij M, Dekker FW et al (2011) Full loss of residual renal function causes higher mortality in dialysis patients; findings from a marginal structural model. Nephrol Dial Transplant 26:2978–2983
38. Marquez IO, Tambra S, Luo FJ et al (2011) Contribution of residual renal function to removal of protein-bound solutes in hemodialysis. Clin J Am Soc Nephrol 6:290–296
39. Menon MK, Naimark DM, Bargman JM et al (2001) Long-term blood pressure control in a cohort of peritoneal dialysis patients and its association with residual renal function. Nephrol Dial Transplant 16:2207–2213
40. Wang AY, Wang M, Woo J et al (2002) A novel association between residual renal function and left ventricular hyperthrophy in peritoneal dialysis patients. Kidney Int 62:639–647
41. Suri RS, Larive B, Sherer S et al (2013) Risk of vascular access complications with frequent hemodialysis. J Am Soc Nephrol 24:498–505
42. Liu S, Diao Z, Zhang D et al (2014) Preservation of residual renal function by not removing water in new hemodialysis patients: a randomized, controlled study. Int Urol Nephrol 46:83–90
43. Libetta C, Nissani P, Dal Canton A (2016) Progressive hemodialysis: is it the future? Semin Dial 29:179–183
44. Foley RN, Gilbertson DT, Murray T et al (2011) Long interdialytic interval and mortality among patients receiving hemodialysis. N Engl J Med 365:1099–1107
45. Zhang H, Schaubel DE, Kalbfleisch JD et al (2012) Dialysis outcomes and analysis of practice patterns suggests the dialysis schedule affects day-of-week mortality. Kidney Int 81:1108–1115
46. Krishnasamy R, Badve SV, Hawley CM et al (2013) Daily variation in death in patients treated by long-term dialysis: comparison of in-center hemodialysis to peritoneal and home hemodialysis. Am J Kidney Dis 61:96–103
47. Rhee CM, Kalantar-Zadeh K (2015) Implications of the long interdialytic gap: a problem of excess accumulation vs. excess removal? Kidney Int 88:442–444
48. Burton JO, Jefferies HJ, Selby NM et al (2009) Hemodialysis-induced cardiac injury: determinants and associated outcomes. Clin J Am Soc Nephrol 4:914–920
49. Shoij T, Tsubakihara Y, Fujii M et al (2004) Hemodialysis-associated hypotension as an independent risk factor for two-year mortality in hemodialysis patients. Kidney Int 66:1212–1220
50. Flythe JE, Kimmel SE, Brunelli SM (2011) Rapid fluid removal during dialysis is associated with cardiovascular morbidity and mortality. Kidney Int 79:250–257
51. Casino FG, Lopez T (1996) The equivalent renal urea clearance: a new parameter to assess dialysis dose. Nephrol Dial Transplant 11:1574–1581
52. Shemin D, Bostom AG, Laliberty P et al (2001) Residual renal function and mortality risk in hemodialysis patients. Am J Kidney Dis 38:85–90
53. (2015) NKF-K/DOQI clinical practice guidelines for hemodialysis adequacy: 2015 update. Am J Kidney Dis 66:884–930
54. European Best Practice Guidelines Expert Group on Haemodialysis (2002) II.3 Haemodialysis dose and residual renal function (Kr). Nephrol Dial Transplant 17(Suppl 7):S24
55. Sargent JA, Gotch FA (1980) Mathematic modeling of dialysis therapy. Kidney Int Suppl 10:S2–S10
56. Vilar E, Farrington K (2011) Emerging importance of residual renal function in end-stage renal failure. Semin Dial 24:487–494
57. Fry AC, Singh DK, Chandna SM et al (2007) Relative importance of residual renal function and convection in determining beta-2-microglobulin levels in high-flux haemodialysis and on-line haemodiafiltration. Blood Purif 25:295–302
58. Penne EL, van der Weerd NC, Blankestijn PJ et al (2010) Role of residual kidney function and convective volume on change in beta2-microglobulin levels in hemodiafiltration patients. Clin J Am Soc Nephrol 5:80–86
59. Oates T, Pinney JH, Davenport A (2011) Haemodiafiltration versus high-flux haemodialysis: effects on phosphate control and erythropoietin response. Am J Nephrol 33:70–75
60. Vilar E, Boltiador C, Viljoen A et al (2014) Removal and rebound kinetics of cystatin C in high-flux hemodialysis and hemodiafiltration. Clin J Am Soc Nephrol 9:1240–1247
61. Bammens B, Evenepoel P, Verbeke K et al (2003) Removal of middle molecules and protein-bound solutes by peritoneal dialysis and relation with uremic symptoms. Kidney Int 64:2238–2243
62. Masereeuw R, Mutsaers HA, Toyohara T et al (2014) The kidney and uremic toxin removal: glomerulus or tubule? Semin Nephrol 34:191–208
63. Gotch FA, Sargent JA (1985) A mechanistic analysis of the National Cooperative Dialysis study (NCDS). Kidney Int 28:526–534
64. Basile C, Lomonte C (2012) Kt/V urea does not tell it all. Nephrol Dial Transplant 27:1284–1287
65. Penne EL, van der Weerd NC, Grooteman MP et al (2011) Role of residual renal function in phosphate control and anemia management in chronic hemodialysis patients. Clin J Am Soc Nephrol 6:281–289
66. Wang AY, Sea MM, Ip R et al (2001) Independent effects of residual renal function and dialysis adequacy on actual dietary protein, calorie, and other nutrient intake in patients on continuous ambulatory peritoneal dialysis. J Am Soc Nephrol 12:2450–2457
67. Wang AY, Woo I, Wang M et al (2005) Important differentiation of factors that predict outcome in peritoneal dialysis patients with different degrees of residual renal function. Nephrol Dial Transplant 20:396–403
68. Chandna SM, Farrington K (2004) Residual renal function: considerations on its importance and preservation in dialysis patients. Semin Dial 17:196–2001
69. Gotch FA (1998) The current place of urea kinetic modelling with respect to different dialysis modalities. Nephrol Dial Transplant 13(Suppl 6):S10–S14
70. Casino FG, Basile C (2017) The variable target model: a paradigm shift in the incremental haemo dialysis prescription. Nephrol Dial Transplant 32:182–190
71. Teruel-Briones JL, Fernández-Lucas M, Rivera-Gorrin M et al (2013) Progression of residual renal function with an increase in dialysis: haemodialysis versus peritoneal dialysis. Nefrologia 33:640–649
72. Mathew AT, Fishbane S, Obi Y et al (2016) Preservation of residual kidney function in hemodialysis patients: reviving an old concept. Kidney Int 90:262–271